adenosine monophosphate has been researched along with Chronic Hepatitis C in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 5 (83.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dangerfield, T; Johnson, KA | 1 |
| Fujita, Y | 1 |
| Adler, JM; Ambiel, I; Bartenschlager, R; Boulant, S; Bushe, J; Chlanda, P; Cortese, M; Diaz, RS; Fackler, OT; Fares, M; Fathy, M; Gallucci, L; Gruber, AD; Laketa, V; Lucic, B; Lusic, M; Neufeldt, CJ; Savarino, A; Shytaj, IL; Sobhy, MH; Stanifer, ML; Stolp, B; Sutton, RE; Taha Ayoub, A; Tolba, MM; Trimpert, J; Xing, N; Zhao, M; Zimmermann, L | 1 |
| Brunotte, L; Ludwig, S; Mecate-Zambrano, A; Rescher, U; Schloer, S; Tang, J; Zheng, S | 1 |
| Bukh, J; Costa, R; Duarte Hernandez, CR; Fahnøe, U; Feng, S; Galli, A; Gammeltoft, KA; Gottwein, JM; Offersgaard, A; Pham, LV; Ramirez, S; Scheel, TKH; Zhou, Y | 1 |
| Drexler, DM; Grace, JE; Wei, C; Zvyaga, TA | 1 |
1 review(s) available for adenosine monophosphate and Chronic Hepatitis C
| Article | Year |
|---|---|
Mechanisms of inhibition of viral RNA replication by nucleotide analogs.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; Hepatitis C, Chronic; Humans; Kinetics; Nucleotides; RNA, Viral; SARS-CoV-2 | 2021 |
5 other study(ies) available for adenosine monophosphate and Chronic Hepatitis C
| Article | Year |
|---|---|
[Remdesivir for COVID-19].
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; COVID-19 Drug Treatment; Hemorrhagic Fever, Ebola; Hepatitis C, Chronic; Humans; SARS-CoV-2 | 2022 |
The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Cobicistat; COVID-19 Drug Treatment; Cricetinae; Disease Progression; Hepatitis C, Chronic; Humans; Mesocricetus; Pandemics; SARS-CoV-2; Viral Load | 2022 |
Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19 Drug Treatment; Fluoxetine; Hepatitis C, Chronic; Humans; Itraconazole; Pharmaceutical Preparations; SARS-CoV-2 | 2021 |
Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Chlorocebus aethiops; COVID-19 Drug Treatment; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Protease Inhibitors; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells; Viral Protease Inhibitors | 2021 |
Utility of high-resolution accurate MS to eliminate interferences in the bioanalysis of ribavirin and its phosphate metabolites.
Topics: Adenosine Monophosphate; Antiviral Agents; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Glucuronosyltransferase; Hepatitis C, Chronic; Humans; Nucleotides; Ribavirin; Spectrometry, Mass, Electrospray Ionization; Uridine; Uridine Diphosphate; Uridine Monophosphate | 2012 |